Last 14 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Solventum Corporation's quarterly P/E stands at 53.5x, down 41.6% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 86.6% YoY to 2.2x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 8.36 | 53.54 | 2.53 | 37.18 | 24.37 | 91.75 | 24.90 | 25.92 | 12.69 | — | — | — | — |
| — | -41.6% | -89.8% | +43.4% | +92.0% | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.55 | 1.74 | 1.53 | 1.54 | 1.61 | 1.39 | 1.46 | 1.10 | 1.49 | — | — | — | — |
| — | +25.1% | +4.9% | +39.5% | +7.8% | — | — | — | — | — | — | — | — | |
| P/B Ratio | 2.58 | 2.75 | 2.57 | 3.65 | 4.07 | 3.90 | 3.80 | 3.20 | 3.12 | — | — | — | — |
| — | -29.4% | -32.4% | +13.9% | +30.6% | — | — | — | — | — | — | — | — | |
| P/FCF | — | 105.23 | — | 56.30 | — | 31.32 | 39.88 | 7.72 | 8.83 | — | — | — | — |
| — | +235.9% | — | +629.0% | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 7.81 | 2.19 | 15.79 | 15.33 | 18.39 | 16.41 | 11.92 | 11.00 | 9.29 | — | — | — | — |
| — | -86.6% | +32.4% | +39.4% | +98.0% | — | — | — | — | — | — | — | — | |
| EV / EBIT | 7.81 | — | 2.54 | 25.01 | 36.39 | 39.12 | 17.76 | 19.74 | 13.12 | — | — | — | — |
| — | — | -85.7% | +26.7% | +177.3% | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Solventum Corporation's operating margin was 84.0% in Q4 2025, up 77.4 pp QoQ and up 77.4 pp YoY. The trailing four-quarter average of 26.9% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 8.6% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.5% | 49.3% | 56.2% | 54.4% | 53.8% | 53.9% | 56.0% | 54.6% | 58.1% | 56.9% | 58.3% | 57.3% | 56.5% |
| — | -8.6% | +0.4% | -0.5% | -7.4% | -5.2% | -4.0% | -4.6% | +2.8% | +15.8% | -1.5% | — | — | |
| Operating Margin | 26.2% | 84.0% | 6.5% | 9.9% | 7.3% | 6.6% | 13.2% | 11.7% | 18.9% | 19.9% | 24.3% | 20.1% | 18.2% |
| — | +1181.4% | -50.5% | -15.5% | -61.1% | -67.1% | -45.6% | -41.6% | +4.1% | +78.6% | +13.0% | — | — | |
| Net Margin | 18.7% | 3.2% | 60.4% | 4.2% | 6.6% | 1.5% | 5.9% | 4.3% | 11.8% | 13.4% | 22.2% | 15.5% | 14.6% |
| — | +111.1% | +930.8% | -2.6% | -43.7% | -88.8% | -73.6% | -72.3% | -19.3% | +183.3% | +30.2% | — | — |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 38.9% | 1.3% | 29.3% | 2.6% | 4.4% | 1.0% | 4.0% | 2.6% | 3.1% | 3.6% | 6.1% | 2.7% | 2.5% |
| — | +24.6% | +628.5% | -1.6% | +44.2% | -72.4% | -34.4% | -3.1% | +22.4% | +237.3% | +111.3% | — | — | |
| ROA | 10.8% | 0.4% | 8.7% | 0.6% | 0.9% | 0.2% | 0.8% | 0.6% | 1.7% | 2.0% | 3.3% | 2.4% | 2.2% |
| — | +109.9% | +947.6% | +0.1% | -42.9% | -89.1% | -75.1% | -74.2% | -23.1% | +184.1% | — | — | — | |
| ROIC | 16.9% | 14.2% | 1.1% | 1.5% | 1.1% | 1.0% | 2.0% | 1.7% | 1.8% | 2.0% | 3.3% | 2.6% | 2.3% |
| — | +1346.5% | -46.7% | -13.0% | -40.8% | -50.2% | -39.9% | -35.2% | -20.5% | +42.6% | +20.8% | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Solventum Corporation's Debt/EBITDA ratio is 2.4x, down from 19.9x last quarter — at a moderate level that warrants monitoring. Debt/Equity has declined for 5 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.00 | 1.00 | 1.03 | 2.14 | 2.43 | 2.71 | 2.54 | 2.90 | 2.16 | 0.71 | 2.56 | 0.01 | 0.01 |
| — | -63.2% | -59.4% | -26.0% | +12.5% | +280.3% | -0.8% | +23015.8% | +28670.5% | — | — | — | — | |
| Debt / EBITDA | 2.31 | 2.45 | 19.91 | 23.26 | 28.16 | 28.01 | 19.88 | 22.03 | 15.97 | 15.23 | 12.85 | 0.27 | 0.17 |
| — | -91.3% | +0.2% | +5.6% | +76.4% | +83.8% | +54.7% | +8143.2% | +9153.8% | — | — | — | — | |
| Current Ratio | 1.23 | 1.23 | 1.50 | 1.22 | 1.19 | 1.20 | 1.15 | 1.31 | 1.81 | 1.46 | 1.81 | 1.65 | 0.04 |
| — | +2.4% | +29.9% | -6.4% | -34.3% | -17.5% | -36.0% | -20.9% | +4004.7% | -14.3% | — | — | — | |
| Quick Ratio | 0.89 | 0.89 | 1.14 | 0.86 | 0.85 | 0.84 | 0.83 | 0.96 | 1.33 | 0.96 | 1.23 | 1.02 | 0.04 |
| — | +5.4% | +38.2% | -10.6% | -35.7% | -12.1% | -32.7% | -5.7% | +2903.7% | -7.1% | — | — | — | |
| Interest Coverage | 6.29 | 32.90 | 1.54 | 2.08 | 1.46 | 1.27 | 2.57 | 2.14 | 9.77 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 14 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonSolventum Corporation's current P/E is 8.4x. The average P/E over the last 4 quarters is 29.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Solventum Corporation's current operating margin is 26.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Solventum Corporation's business trajectory between earnings reports.